Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
The New England Journal of Medicine|July 8, 1993
Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 geneB B Roa, C A Garcia, U Suter, et al.Nature Genetics|June 1, 1992
The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1AP I Patel, B B Roa, A A Welcher, et al.Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2017
Brief Report: Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti-Interferon-γ Antibody, in Patients With Discoid Lupus ErythematosusVictoria P Werth, David Fiorentino, Barbara A Sullivan, et al.Biochemistry|November 18, 1998
Biochemical, biophysical, and pharmacological characterization of bacterially expressed human agouti-related proteinR D Rosenfeld, L Zeni, A A Welcher, et al.Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2015
Blockade of interferon-γ normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosusAndrew A Welcher, Michael Boedigheimer, Alan J Kivitz, et al.Cellular Immunology|August 4, 2009
CD28 and ICOS play complementary non-overlapping roles in the development of Th2 immunity in vivoRebecca A Shilling, Bryan S Clay, Amanda G Tesciuba, et al.Journal of Autoimmunity|March 30, 2020
Multi-omics: Differential expression of IFN-γ results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseasesHeekyong R Bae, Patrick S C Leung, Deborah L Hodge, et al.American Journal of Respiratory and Critical Care Medicine|December 8, 2016
A Severe Asthma Disease Signature from Gene Expression Profiling of Peripheral Blood from U-BIOPRED CohortsJeannette Bigler, Michael Boedigheimer, James P R Schofield, et al.Lupus Science & Medicine|October 12, 2017
Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritisMichael J Boedigheimer, David A Martin, Zahir Amoura, et al.Journal of Medicinal Chemistry|February 19, 2008
Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activityMatthew W Martin, John Newcomb, Joseph J Nunes, et al.Pageof 7